Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
In this randomized trial, we attempt to further define optimal palliative chemotherapy for
elderly patients with advanced non-small cell lung cancer by comparing single agent treatment
with weekly docetaxel versus combination therapy with weekly docetaxel plus gemcitabine.